About

Fasikl is a NeuroAI company spun out of the University of Minnesota, developing a new generation of AI therapeutics for neurological conditions. Rooted in more than 20 years of neural engineering research and innovation, we believe in science and real-world evidence. Our AI therapeutics are designed to treat disease in fundamentally new ways.

We work for people. Our work begins with understanding the challenges people face in everyday life and developing therapies that can make a meaningful difference. We design our products around patients’ needs, experiences, and quality of life. For eligible patients, we hope to offer not only another treatment choice, but a new opportunity to get better.

That commitment carries through everything we do, from carefully crafting each Felix device to supporting the people who use it. We listen, learn, and keep improving.